Synnovation Therapeutics
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $102M
Overview
A precision oncology company creating targeted small molecule therapies based on genetic insights.
Oncology
Technology Platform
A genetics-driven platform that uses human genomic data to identify and validate novel oncology targets for small molecule drug development.
Funding History
1Total raised:$102M
Venture$102M
Opportunities
Potential to achieve high response rates in niche, genetically-defined cancer populations, enabling accelerated regulatory pathways and premium pricing.
Risk Factors
Risk of narrow patient populations limiting commercial potential, and competition from similar targeted therapies or next-generation modalities.
Competitive Landscape
Competes directly with many larger precision oncology companies and must prove its targets offer a superior therapeutic window or address an unmet need missed by others.